ABBOTT WELCOMES YOU TO EUROPCR 2017

Abbott and St. Jude Medical have joined together – combining our strengths, passion to achieve, and ability to change lives for the better.

Join us at EuroPCR 2017 to discover more options, breakthrough solutions, expertise and support.

We wish you a great time at EuroPCR 2017.

VISIT OUR BOOTH AND INNOVATION PAVILION

  • 1INNOVATION PAVILION
    Discover our latest innovations, and what’s coming next, in structural heart and percutaneous coronary intervention (PCI).
  • 2STRUCTURAL HEART
    Learn about our latest structural heart advancements to help your patients live healthy and full lives.
  • 3PCI
    Unlock the potential of PCI through greater accuracy, improved access and enhanced treatment.
  • 4BARISTA ZONE
  • 5LOUNGE AREA
  • TRAINING VILLAGE & REGISTRATIONRegister at the Training Village for on-site, purpose-built training modules - unlock the potential of PCI.

JOIN US AT OUR SCIENTIFIC SESSIONS All-in-One_Sessions-EuroPCR2017

TUESDAY 16TH MAY

STENTS OR SCAFFOLDS: RELEVANT OPTIONS FOR OPTIMAL PATIENT OUTCOMES?

ABBOTT SPONSORED CASE IN POINT SESSION:
17:15–18:45, Room: Maillot

Chairpersons: D. Dudek, J. Fajadet
Panellists: D. Capodanno, N.E.J. West, T. Lefevre, A.S. Petronio, A. Serra, V. Kocka

A bifurcation strategy needed for my patient: stent or scaffold? T. Lefevre
How would I treat this case? D. Capodanno

Treatment of a young patient with long lesions: stent or scaffold? A.S. Petronio
How would I treat this case? N.E.J. West

A patient with a long tapered CTO lesion: stent or scaffold? A. Serra
How would I treat this case? D. Capodanno

My patient needs primary PCI: stent or scaffold? V. Kocka
How would I treat this case? N.E.J. West

ICS
SELF-EXPANDING TAVI TECHNOLOGY – HOW TO SAFEGUARD SIMPLICITY, SAFETY AND EFFECTIVENESS?

ABBOTT SPONSORED TOOLS AND TECHNIQUES SESSION:
17:15–18:45, Room: Theatre Bordeaux

Chairpersons: L. Sondergaard, S. Worthley, F. Nietlispach
Panellists: S. Fichtlscherer, A. Linke, U. Schaefer, H. Moellman

How to deploy the Portico™ valve? Step by step procedure based on expert consensus – recorded case from Rigshospitalet, Copenhagen – Denmark
L. Sondergaard

Lecture 1
S. Fichtlscherer

Challenging cases in elderly patients: targeting minimal vascular complications and a low new pacemaker implantation rate – recorded case from University of Leipzig, Heart Center – Germany
A. Linke

Lecture 2
U. Schaefer

ICS

WEDNESDAY 17TH MAY

STEMI AND MULTIVESSEL DISEASE: EVIDENCE ON FFR-GUIDED TREATMENT PUT INTO PRACTICE

ABBOTT SPONSORED SYMPOSIUM:
12:30–13:30, Room: 351

Chairpersons: E. Barbato, P. Smits
Panellist: P. MacCarthy

STEMI patient with multivessel disease – reviewing treatment options
P. Smits

The role of FFR in guiding treatment of non-culprit lesions in acute patients
P. MacCarthy

Case: implementing the available evidence in my practice
E. Barbato

ICS
HOW TO BEST MANAGE CONCOMITANT PROCEDURES IN STRUCTURAL HEART THERAPIES?

ABBOTT SPONSORED CASE IN POINT SESSION:
12:30–13:30, Room: 251

Chairpersons: F. Maisano, D. Tchétché
Panellists: L. Sondergaard, D. Arzamendi

How to best treat bi-valvular disease in TAVI patients; concomitant procedures or staged?
L. Sondergaard

Is there a future for LAA occlusion therapy in atrial fibrillation patients indicated for TAVI?
D. Arzamendi

ICS
TRANSCATHETER MITRAL VALVE REPLACEMENT AND REPAIR: WHAT’S THE FUTURE?

ABBOTT SPONSORED SYMPOSIUM:
13:35–14:35, Room: 251

Chairpersons: C. Tamburino, A. Vahanian
Panellists: C. Frerker, F. Maisano, S. Von Bardeleben

Functional mitral regurgitation patients: when to treat with MitraClip NT?
C. Frerker

MitraClip NT: improving patient outcomes
Case 1: S. Von Bardeleben
Case 2: C. Frerker

WHO are the patients to benefit from transcatheter mitral valve replacement and repair?
S. Von Bardeleben

The future of transcatheter mitral valve interventions
F. Maisano

ICS
INTRODUCTION TO POLYMER TECHNOLOGY – WHAT IS RELEVANT FOR THE INTERVENTIONAL CARDIOLOGIST

ABBOTT & CVPATH SPONSORED SYMPOSIUM:
16:30–18:00, Room: 252B

Chairpersons: R. Virmani, W. Wijns
Panellists: B. Ratner, A. Finn, T. Palmerini, J. Diaz

Biomaterials in blood contact applications
B. Ratner

Pre-clinical evidence on DES performance
A. Finn

Clinical evidence on DES performance
T. Palmerini

Case presentation
J. Diaz

ICS
HOW TO OPTIMISE PCI WITH ADVANCED IMAGING TECHNOLOGIES: BENEFITS OF THE COMBINED USE OF OCT AND FLUORO REAL-TIME STENT ENHANCEMENT

ABBOTT & SIEMENS HEALTHINEERS SPONSORED TOOLS AND TECHNIQUES SESSION:
16:30–18:00, Room: Theatre Bleu

Chairpersons: A. Baumbach, N. Meneveau
Panellists: F. Burzotta, N. Gonzalo

Complex lesions: which PCI approach according to guidelines?
N. Gonzalo

The added value of OCT and real-time stent enhancement in the decision-making process
A. Baumbach

LIVE demonstration from Swiss Cardiovascular Centre, Bern University Hospital – Bern, Switzerland

PCI in bifurcations: a glimpse into the future of OCT-guided PCI

F. Burzotta

ICS
LAA OCCLUSION THERAPY IN THE REAL WORLD

ABBOTT SPONSORED SYMPOSIUM:
16:30–17:30, Room: 251

Chairperson: H. Sievert, G. Tarantini
Panellists: D. Hildick-Smith, J.E. Nielsen-Kudsk, G. Montalescot

Recent published data on outcomes and procedure for LAA occlusion
D. Hildick-Smith

ICE as imaging modality for LAA device implant; toy or tool?
J.E. Nielsen-Kudsk

Building the referral network; it is not as simple as it sounds
G. Montalescot

ICS

THURSDAY 18TH MAY

APPLICATION OF THE ILUMIEN III PCI OPTIMISATION CRITERIA IN THE REAL WORLD

ABBOTT SPONSORED TOOLS AND TECHNIQUES SESSION:
12:30–14:00, Room: Theatre Havane

Chairpersons: T. Johnson, L. Räber
Panellists: Z. Ali, U. Landmesser

ILUMIEN III: from clinical outcomes to new optimisation criteria
Z. Ali

LIVE demonstration from Cardiovascular Research Center OLV Aalst – Aalst, Belgium

Does ILUMIEN III change my practice?

T. Johnson

ILUMIEN IV: what is the future of OCT guidance in PCI?
U. Landmesser

ICS
BVS: REVIEWING THE EVIDENCE AND DISTILLING THE LEARNINGS

ABBOTT SPONSORED SYMPOSIUM:
12:30–14:00, Room: Maillot

Chairpersons: W. Wijns, C.K. Naber, G.W. Stone
Panellists: A. Al Nooryani, A. Seth, A. Latib

BVS – review and analyse the data from randomised studies
G.W. Stone

BVS – real-world evidence – what did we learn?
C.K. Naber

2017: rationale for choosing BVS for my patients
A. Latib

ICS

ABBOTT TRAINING VILLAGE

Join us to gain extensive expertise and experience of working with our Abbott technologies. We offer hands-on exercises and practical insight into how and when to use the broad range of advanced technologies offered by Abbott to optimise patient outcomes in your daily practice.

To sign-up, please contact your Abbott sales representative, or visit us at the Training Village.

A WIDE RANGE OF SESSIONS ON OFFER:

  • Fellow sessions in support of the Fellow Program
  • FFR sessions to explore FFR advancements
  • OCT sessions to optimise use and interpretation, including in PCI
  • Structural Heart product sessions including:
    – Vessel closure, MitraClip, LAAO and TAVI
  • Vascular product sessions including:
    – Guidewires, drug-eluting stents and bioresorbable scaffolds

DOWNLOAD OUR TRAINING VILLAGE BOOKLET

SIGN-UP FOR FUTURE UPDATES

Page 1